BTG Interventional Oncology is transforming cancer care with smarter solutions

BTG Interventional Oncology is transforming the way cancer is treated with our wide-ranging solutions of minimally-invasive, highly targeted cancer therapies.

Explore io

show favorites
ICEfx global launch

ICEfx™ global launch

News
28 Apr
Oxford, UK

UK Trial of radioactive glass particles to tackle cancer

Cancer treatment with radioactive glass microspheres is to be trialled for the first time in the UK at Oxford's Churchill Hospital.
Update
London, UK

BTG ANNOUNCES GLOBAL LAUNCH OF THE ICEfx™ CRYOABLATION SYSTEM

September 20, 2018: BTG plc (LSE: BTG), a global specialist healthcare company, today announced the global launch of the ICEfx Cryoablation System. ICEfx, an evolution of the existing Visual ICE system, offers predictable, reliable performance with seamless therapy delivery and exceptional ease of technical operation. This compact and powerful console is designed for interventional radiologists who want to offer their patients state-of-the-art, minimally invasive treatment options.
Product
LC Bead LUMI™

LC Bead LUMI™

With LC Bead LUMI™, you are empowered to see the location of the beads during and after embolization.
Video

BTG@CIRSE 2017 - hands-on sessions

Events
07-08 Dec 18

GEST ASIA 2018

Hong Kong, Hong Kong S.A.R.
Events
01 Nov 18

Synergy: A Multidisciplanary Approach to Interventional Oncology

Miami Beach, FL, United States
Video

LC Bead LUMI™

Building on the established clinical performance of LC Bead®, LC Bead LUMI™ provides real-time visible confirmation of bead location during embolization.
Update
London, UK

Institutional Decision to Adopt Y90 TARE with TheraSphere® as first-line treatment for HCC

Based on experience with 1000 patients over 15 years, the largest single-centre, prospective centre cohort of patients with HCC treated with Y90 glass microspheres
News
30 Mar
Huffington Post

The ‘Pinhole’ Cancer Treatment You’ve Probably...

Imagine an exquisitely precise cancer therapy procedure done through a small opening in the body
Let's Stay In Touch!

Let’s stay in touch!

Please visit our preference centre to update your email settings
BTG @CIRSE 2017

BTG @CIRSE 2017

News
05 Apr
London, UK

NICE highlights potential role of TheraSphere® for...

BTG plc (LSE: BTG), a global specialist healthcare company, has today announced the publication of a new medtech innovation briefing (MIB) by NICE ...
Update
London, UK

BTGplc acquires Roxwood Medical

London, UK, 5 October 2017: BTG plc (LSE: BTG), the global specialist healthcare company, today announces it has acquired Roxwood Medical (“Roxwood”), an innovative provider of advanced cardiovascular specialty catheters used in the treatment of patients with severe coronary and peripheral artery disease.
Video

TheraSphere®

TheraSphere® yttrium-90 glass microspheres deliver a targeted radiation dose to the tumour whilst minimising exposure to healthy tissue with mild to...
Events
14-16 Nov 18

BSIR - British Society of Interventional Radiology

Bournemouth, United Kingdom
Video

US TheraSphere® Vial Flushing

Update
London, UK

Mirada Medical signs three-year software development agreement with BTG

Mirada Medical Ltd, a global medical imaging software company, has signed a three-year master service agreement with BTG plc (LSE: BTG), a global specialist healthcare company. The agreement covers multiple software development projects to support BTG’s portfolio of interventional medicine products.
News
12 Apr
Indiana

New procedure uses tiny beads to blast away liver cancer

Treating cancer that began in the liver or has spread to the liver can often involve months of chemotherapy and painful radiation treatments. But...
SIR 2017
The Interventional Initiative

The Interventional Initiative

Update
N/A

BTG and SIO expand Immuno-Oncology / Interventional Oncology grant programme

BTG plc (LSE: BTG), a global specialist healthcare company, and the Society of Interventional Oncology (SIO), an international organisation working to nurture and support interventional oncology worldwide, have expanded their commitment to the Immuno-Oncology / Interventional Oncology research grant programme, by announcing a second round of funding available to investigators.
@BTGIO

 @BTGIO

Twitter No2

 @BTGIO

Twitter No1

 @BTGIO

CRYOABLATION

CRYOABLATION

Breaking Boundaries with Ice
LOAD MORE CONTENT

Explore io solution

ENGAGE WITH BTGIO

Our whole world is interventional oncology and if yours is too we want to hear from you Get in touch
Your name is
   
Your company is
   
Your email is
   
Your question is
image image image image